Skip to main content
letter
. 2018 Mar 12;8(3):32. doi: 10.1038/s41408-018-0057-8

Table 1.

Spectrum of TET1, TET3 and ASXL2 mutations and variants of unclear significance in patients with MDS/MPN overlap syndromes

Gene Chr Position Nucleotide nomenclature Protein consequence Disease type Alt Frac ExAC dbSNP Cosmic # Cited as somatic Cosmic Annotated Disease Type Exon Phenotype Prediction Concurrent Mutations
TET1 10 70404533 c.2047C > G Q683E CMMLb 46% 0.08400% rs139785845 COSM327333 yes ALL1, Sezary Syndrome2 4 MODERATE TET3Y473a (43%) ASXL1G646Wfsa12 (26%) PTPN11N308D (14%)
70450700 c.5540G > T G1847V MDS/MPNu 52% n/a n/a n/a 12 MODERATE SRSF2P95R (53%) NRASG13D (41%)
TET3 2 74274463 c.1419C > A Y473 a CMMLb 43% n/a n/a n/a 3 HIGH TET1Q683E (46%) ASXL1G646Wfsa12 (26%) PTPN11N308D (14%)
74329187 c.5278_5280del K1760del CMML 48% 0.02900% rs564392898 n/a 11 MODERATE PHF6F172Lfsa46 (88%)
74327798 c.3883G > A V1295I CMML 51% 0.04400% rs199849765 n/a 11 MODERATE CEBPAH195_P196dup (57%) ATML1111P (51%) ASXL1L775a (49%) JARID2R767K (46%)
74327893 c.3980_3981insACTGAG N1326_S1327insRL CMMLa 41% 0.00860% rs768310475 n/a 11 MODERATE SRSF2P95T (45%) TET3L1328P (42%)
74327898 c.3983T > C L1328P CMMLa 42% 0.00860% rs767538752 n/a 11 MODERATE SRSF2P95T (45%) TET3N1326_S1327insRL (41%)
74328177 c.4262C > G P1421R CMML 51% 0.00940% rs745953793 n/a 11 MODERATE SH2B3R140H (58%) JARID2P1229L (52%) NRASQ61K (47%) RUNX1G199W (21%)
74329152 c.5237G > T W1746L MDS/MPNu 49% 0.06500% rs190925009 n/a 11 MODERATE SRSF2P95L (49%) ASXL1P808H (49%) JAK2V617F (49%)
ASXL2 2 25966302 c.2902_2903dupCT P969Cfs a 10 MDS/MPNu 22% n/a . n/a 13 HIGH SRSF2P95_R102del (15%) RUNX1R237K (38%)
25967305 c.1901C > A_p.Ser634X S634 a MDS/MPNu 20% n/a . n/a 13 HIGH SRSF2R94dup (39%)
25965934 c.3272 C>T_p.Ala1091Val A1091V CMML 51% 0.01300% rs781151810 n/a 13 MODERATE ZRSR2 c.400-2A > G (92%) MPLV368L (49%) ASXL1G646Wfsa12 (44%) SETBP1D868N (43%) RUNX1T246Hfsa15 (35%)
26101079 c.13G > A_p.Gly5Arg G5R MDS/MPNu 51% 0.01200% rs371056638 n/a 1 MODERATE EZH2 c.1411-1G > A (91%) ASXL1R417a (45%) JARID2R326C (48%) SUZ12N263H (47%)

Values in italic denote cited pathogenic mutation or variants which truncate the protein

a Mutations in same patient (TET3N1326_S1327insRL and TET3L1328P)

b Mutations in same patient (TET1Q683E and TET3Y473a)

c Ref. 12

d Ref. 13

e Ref. 14

f Ref. 15